Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus
- PMID: 1548769
- PMCID: PMC289034
- DOI: 10.1128/JVI.66.4.2389-2397.1992
Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus
Abstract
The entry of human immunodeficiency virus type 1 (HIV-1) into target cells involves binding to the viral receptor (CD4) and membrane fusion events, the latter influenced by target cell factors other than CD4. The third variable (V3) region of the HIV-1 gp120 exterior envelope glycoprotein and the amino terminus of the HIV-1 gp41 transmembrane envelope glycoprotein have been shown to be important for the membrane fusion process. Here we demonstrate that some HIV-1 envelope glycoproteins containing an altered V3 region or gp41 amino terminus exhibit qualitatively different abilities to mediate syncytium formation and virus entry when different target cells are used. These results demonstrate that the structure of these HIV-1 envelope glycoprotein regions determines the efficiency of membrane fusion in a target cell-specific manner and support a model in which the gp41 amino terminus interacts directly or indirectly with the target cell during virus entry.
Similar articles
-
Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.J Virol. 1992 Sep;66(9):5516-24. doi: 10.1128/JVI.66.9.5516-5524.1992. J Virol. 1992. PMID: 1501286 Free PMC article.
-
Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo.J Virol. 2000 May;74(9):4433-40. doi: 10.1128/jvi.74.9.4433-4440.2000. J Virol. 2000. PMID: 10756060 Free PMC article.
-
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.J Virol. 1993 May;67(5):2747-55. doi: 10.1128/JVI.67.5.2747-2755.1993. J Virol. 1993. PMID: 8474172 Free PMC article.
-
CD4 activation of HIV fusion.Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review.
-
Cytopathic mechanisms of HIV-1.Virol J. 2007 Oct 18;4:100. doi: 10.1186/1743-422X-4-100. Virol J. 2007. PMID: 17945027 Free PMC article. Review.
Cited by
-
Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.J Virol. 1994 Feb;68(2):1029-39. doi: 10.1128/JVI.68.2.1029-1039.1994. J Virol. 1994. PMID: 7904656 Free PMC article.
-
Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.J Virol. 1998 Jun;72(6):4765-74. doi: 10.1128/JVI.72.6.4765-4774.1998. J Virol. 1998. PMID: 9573241 Free PMC article.
-
Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences.J Virol. 1994 Nov;68(11):7467-81. doi: 10.1128/JVI.68.11.7467-7481.1994. J Virol. 1994. PMID: 7933130 Free PMC article.
-
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4. doi: 10.1073/pnas.91.21.9770. Proc Natl Acad Sci U S A. 1994. PMID: 7937889 Free PMC article.
-
Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E.J Virol. 1998 Feb;72(2):1632-9. doi: 10.1128/JVI.72.2.1632-1639.1998. J Virol. 1998. PMID: 9445069 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials